Abstract
Acute lymphoblastic leukemia (ALL) is an aggressive cancer that occurs in both children and adults. Starting from an integrated analysis of miRNA/mRNA expression profiles in 20 ALL patients, we identify a negative correlation between miR-181a and EGR1. Coherently, miR-181a over-expression in Jurkat T-ALL cells decreases EGR1 expression, increasing cell proliferation and enhancing the cell-cycle progression from G1 to S phase. We show that EGR1 is a new direct target of miR-181a. Our findings suggest that miR-181a behaves as an onco-miRNA in ALL by down-regulating EGR1.
Keywords:
Acute lymphoblastic leukemia (ALL); Cell cycle; Cell proliferation; EGR1; miR-181a; onco-miRNA.
Copyright © 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Apoptosis
-
Biomarkers, Tumor / genetics*
-
Biomarkers, Tumor / metabolism
-
Blotting, Western
-
Cell Cycle
-
Cell Proliferation*
-
Early Growth Response Protein 1 / genetics
-
Early Growth Response Protein 1 / metabolism*
-
Gene Expression Profiling
-
Humans
-
Immunoenzyme Techniques
-
MicroRNAs / genetics*
-
Oligonucleotide Array Sequence Analysis
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics*
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / metabolism
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / pathology*
-
RNA, Messenger / genetics
-
Real-Time Polymerase Chain Reaction
-
Reverse Transcriptase Polymerase Chain Reaction
-
Tumor Cells, Cultured
Substances
-
Biomarkers, Tumor
-
EGR1 protein, human
-
Early Growth Response Protein 1
-
MIrn181 microRNA, human
-
MicroRNAs
-
RNA, Messenger